RE Dickinson Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.72M | Buy |
965
+1
| +0.1% | +$1.78K | 0.1% | 53 |
|
|
2024
Q3 | $190K | Hold |
964
| – | – | 0.11% | 49 |
|
|
2024
Q2 | $165K | Hold |
964
| – | – | 0.1% | 53 |
|
|
2024
Q1 | $176K | Hold |
964
| – | – | 0.11% | 48 |
|
|
2023
Q4 | $149K | Hold |
964
| – | – | 0.1% | 49 |
|
|
2023
Q3 | $144K | Hold |
964
| – | – | 0.1% | 50 |
|
|
2023
Q2 | $130K | Hold |
964
| – | – | 0.05% | 105 |
|
|
2023
Q1 | $154K | Hold |
964
| – | – | 0.05% | 100 |
|
|
2022
Q4 | $156K | Hold |
964
| – | – | 0.06% | 88 |
|
|
2022
Q3 | $250K | Hold |
964
| – | – | 0.21% | 34 |
|
|
2022
Q2 | $147 | Hold |
964
| – | – | 0.02% | 48 |
|
|
2022
Q1 | $156K | Buy |
964
+59
| +7% | +$9.55K | 0.1% | 46 |
|
|
2021
Q4 | $123K | Buy |
+905
| New | +$123K | 0.09% | 49 |
|